These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

260 related articles for article (PubMed ID: 2523955)

  • 1. Elimination of CD4+ suppressor T cells from susceptible BALB/c mice releases CD8+ T lymphocytes to mediate protective immunity against Leishmania.
    Hill JO; Awwad M; North RJ
    J Exp Med; 1989 May; 169(5):1819-27. PubMed ID: 2523955
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Establishment of resistance to Leishmania major infection in susceptible BALB/c mice requires parasite-specific CD8+ T cells.
    Müller I; Pedrazzini T; Kropf P; Louis J; Milon G
    Int Immunol; 1991 Jun; 3(6):587-97. PubMed ID: 1909563
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduced numbers of CD4+ suppressor cells with subsequent expansion of CD8+ protective T cells as an explanation for the paradoxical state of enhanced resistance to Leishmania in T-cell deficient BALB/c mice.
    Hill JO
    Immunology; 1991 Feb; 72(2):282-6. PubMed ID: 1826673
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cellular and humoral immunity to Leishmania major in genetically susceptible mice after in vivo depletion of L3T4+ T cells.
    Sadick MD; Heinzel FP; Shigekane VM; Fisher WL; Locksley RM
    J Immunol; 1987 Aug; 139(4):1303-9. PubMed ID: 3112230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunological regulation of experimental cutaneous leishmaniasis. III. Nature and significance of specific suppression of cell-mediated immunity in mice highly susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1980 Sep; 152(3):594-607. PubMed ID: 6447751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. L3T4+ T cells promoting susceptibility to murine cutaneous leishmaniasis express the surface marker Ly-24 (Pgp-1).
    Moll H; Scollay R
    Eur J Immunol; 1989 Feb; 19(2):307-14. PubMed ID: 2467816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylactic immunization against experimental leishmaniasis. V. Mechanism of the anti-protective blocking effect induced by subcutaneous immunization against Leishmania major infection.
    Liew FY; Singleton A; Cillari E; Howard JG
    J Immunol; 1985 Sep; 135(3):2102-7. PubMed ID: 3160786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Factors influencing the host response to Leishmania mexicana.
    Pérez H
    Ciba Found Symp; 1983; 99():157-73. PubMed ID: 6227462
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Higher frequency of Leishmania major-specific L3T4+ T cells in susceptible BALB/c as compared with resistant CBA mice.
    Milon G; Titus RG; Cerottini JC; Marchal G; Louis JA
    J Immunol; 1986 Feb; 136(4):1467-71. PubMed ID: 2418115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CD4 monoclonal antibody in vivo on lesion development, delayed-type hypersensitivity and interleukin 3 production in experimental murine cutaneous leishmaniasis.
    Liew FY; Millott S; Lelchuk R; Cobbold S; Waldmann H
    Clin Exp Immunol; 1989 Mar; 75(3):438-43. PubMed ID: 2784747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological regulation of experimental cutaneous leishmaniasis. IV. Prophylactic effect of sublethal irradiation as a result of abrogation of suppressor T cell generation in mice genetically susceptible to Leishmania tropica.
    Howard JG; Hale C; Liew FY
    J Exp Med; 1981 Mar; 153(3):557-68. PubMed ID: 6454739
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to cutaneous leishmaniasis in nude mice injected with L3T4+ T cells but not with Ly-2+ T cells.
    Moll H; Scollay R; Mitchell GF
    Immunol Cell Biol; 1988 Feb; 66 ( Pt 1)():57-63. PubMed ID: 3259538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunity to experimental infection with Leishmania major: generation of protective L3T4+ T cell clones recognizing antigen(s) associated with live parasites.
    Müller I; Louis JA
    Eur J Immunol; 1989 May; 19(5):865-71. PubMed ID: 2500348
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic immunization against experimental leishmaniasis. III. Protection against fatal Leishmania tropica infection induced by irradiated promastigotes involves Lyt-1+2- T cells that do not mediate cutaneous DTH.
    Liew FY; Howard JG; Hale C
    J Immunol; 1984 Jan; 132(1):456-61. PubMed ID: 6228580
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Involvement of specific Lyt-2+ T cells in the immunological control of experimentally induced murine cutaneous leishmaniasis.
    Titus RG; Milon G; Marchal G; Vassalli P; Cerottini JC; Louis JA
    Eur J Immunol; 1987 Oct; 17(10):1429-33. PubMed ID: 3119350
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of L3T4+ and LyT-2+ cells in experimental visceral leishmaniasis.
    Stern JJ; Oca MJ; Rubin BY; Anderson SL; Murray HW
    J Immunol; 1988 Jun; 140(11):3971-7. PubMed ID: 3131421
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunologic regulation of experimental cutaneous leishmaniasis. V. Characterization of effector and specific suppressor T cells.
    Liew FY; Hale C; Howard JG
    J Immunol; 1982 Apr; 128(4):1917-22. PubMed ID: 6120976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Distinctive cellular immunity in genetically susceptible BALB/c mice recovered from Leishmania major infection or after subcutaneous immunization with killed parasites.
    Liew FY; Dhaliwal JS
    J Immunol; 1987 Jun; 138(12):4450-6. PubMed ID: 3295049
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunoregulatory pathways in murine leishmaniasis: different regulatory control during Leishmania mexicana mexicana and Leishmania major infections.
    Alexander J; Kaye PM
    Clin Exp Immunol; 1985 Sep; 61(3):674-82. PubMed ID: 3907906
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Specific suppressor T cells for delayed-type hypersensitivity in susceptible mice immunized against cutaneous leishmaniasis.
    Dhaliwal JS; Liew FY; Cox FE
    Infect Immun; 1985 Aug; 49(2):417-23. PubMed ID: 3160663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.